From Discovery to Cure: Understanding the Complex Path of Antiherpetic Drug Development

We often hear headlines about breakthrough discoveries and promising new therapies for herpes — only to hear nothing more about them months or even years later. Why do so manyContinueContinue reading “From Discovery to Cure: Understanding the Complex Path of Antiherpetic Drug Development”

Year-End Giving | Research Is Moving Us Closer to a Cure

For decades, people living with herpes have been told to “just live with it.” But science is proving that answer is no longer acceptable. Thanks to growing research momentum —ContinueContinue reading “Year-End Giving | Research Is Moving Us Closer to a Cure”

🚨 Big News in Herpes Research: Promising Phase 1b Results from Assembly Biosciences 🚨

There’s major progress happening in the fight against HSV-2. Assembly Biosciences (ASMB) has reported very promising interim results from two Phase 1b clinical studies testing their new investigational treatments forContinueContinue reading “🚨 Big News in Herpes Research: Promising Phase 1b Results from Assembly Biosciences 🚨”

 Herpes Cure Advocacy Makes Push for Neonatal Herpes as Reportable Condition

Herpes Cure Advocacy is advocating to make the neonatal herpes infection reportable via a recommendation from the Committee of State and Territorial Epidemiologists (CSTE). Neonatal herpes is a rare disease thatContinueContinue reading ” Herpes Cure Advocacy Makes Push for Neonatal Herpes as Reportable Condition”

Herpes Cure Advocacy Attends the 2025 STI & HIV World Congress

Montréal, Canada This year, members of Herpes Cure Advocacy attended the STI & HIV World Congress in Montréal, Canada — a global gathering of researchers, clinicians, public health leaders, andContinueContinue reading “Herpes Cure Advocacy Attends the 2025 STI & HIV World Congress”

New Gilead-Funded Study Supports Hypothesis that HSV-1 Significantly Increases Alzheimer’s Disease Risk

Here are our key takeaways from the study “Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study” published in BMJ Open onContinueContinue reading “New Gilead-Funded Study Supports Hypothesis that HSV-1 Significantly Increases Alzheimer’s Disease Risk”